Whole genome amplification of DNA from laser capture-microdissected tissue for high-throughput single nucleotide polymorphism and short tandem repeat genotyping.

Genome-wide screening of genetic alterations between normal and cancer cells, as well as among subgroups of tumors, is important for establishing molecular mechanism and classification of cancer. Gene silencing through loss of heterozygosity is widely observed in cancer cells and detectable by analyzing allelic loss of single nucleotide polymorphism and/or short tandem repeat markers. To use minute quantities of DNA that are available through laser capture microdissection (LCM) of cancer cells, a whole genome amplification method that maintains locus and allele balance is essential. We have successfully used a ø29 polymerase-based isothermal whole genome amplification method to amplify LCM DNA using a proteinase K lysis procedure coupled with a pooling strategy. Through single nucleotide polymorphism and short tandem repeat genotype analysis we demonstrate that using pooled DNA from two or three separate amplification reactions significantly reduces any allele bias introduced during amplification. This strategy is especially effective when using small quantities of source DNA. Although a convenient alkaline lysis DNA extraction procedure provided satisfactory results from using 1500 to 3000 LCM cells, proteinase K digestion was superior for lower cell numbers. Accurate genotyping is achieved with as few as 100 cells when both proteinase K extraction and pooling are applied.

[1]  S. Grant,et al.  SNP genotyping on a genome-wide amplified DOP-PCR template. , 2002, Nucleic acids research.

[2]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Berkowitz,et al.  Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. , 2001, Cancer research.

[4]  David E. Housman,et al.  Genome complexity reduction for SNP genotyping analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Kristjánsson,et al.  Preimplantation single-cell analysis of multiple genetic loci by whole-genome amplification. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M S Waterman,et al.  Whole genome amplification of single cells: mathematical analysis of PEP and tagged PCR. , 1995, Nucleic acids research.

[7]  L. Staudt,et al.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.

[8]  S. Kingsmore,et al.  Comprehensive human genome amplification using multiple displacement amplification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Berns,et al.  Haplo-insufficiency? Let me count the ways. , 2001, Genes & development.

[10]  O. Kallioniemi,et al.  Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.

[11]  V G Cheung,et al.  Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Paunio,et al.  Preimplantation diagnosis by whole-genome amplification, PCR amplification, and solid-phase minisequencing of blastomere DNA. , 1996, Clinical chemistry.

[13]  J. Izbicki,et al.  SCOMP is superior to degenerated oligonucleotide primed-polymerase chain reaction for global amplification of minute amounts of DNA from microdissected archival tissue samples. , 2002, The American journal of pathology.

[14]  Allen D. Roses,et al.  Genome-based pharmacogenetics and the pharmaceutical industry , 2002, Nature Reviews Drug Discovery.

[15]  S. Thiagalingam,et al.  Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence , 2002, Current opinion in oncology.

[16]  R. Hubert,et al.  Whole genome amplification from a single cell: implications for genetic analysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[18]  L. Liotta,et al.  Laser capture microdissection. , 2006, Methods in molecular biology.

[19]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[20]  T. Furuya,et al.  Detection of Genetic Alterations in Pancreatic Cancers by Comparative Genomic Hybridization Coupled with Tissue Microdissection and Degenerate Oligonucleotide Primed Polymerase Chain Reaction , 2002, Oncology.

[21]  S. Andrew,et al.  DNA Instability and Human Disease , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[22]  A. Hartmann,et al.  Multiple mutation analyses in single tumor cells with improved whole genome amplification. , 1999, The American journal of pathology.

[23]  Roger S Lasken,et al.  Unbiased whole-genome amplification directly from clinical samples. , 2003, Genome research.

[24]  Francisco M De La Vega,et al.  New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies. , 2002, BioTechniques.